Edition:
United States

NanoViricides Inc (NNVC.A)

NNVC.A on American Stock Exchange

1.01USD
20 Oct 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.01
Open
$1.00
Day's High
$1.03
Day's Low
$1.00
Volume
13,173
Avg. Vol
12,115
52-wk High
$1.64
52-wk Low
$0.96

Chart for

About

NanoViricides, Inc. is a nano-biopharmaceutical company. The Company is a development-stage company with several drugs in various stages of development. The Company focuses on its research and clinical programs on specific anti-viral therapeutics. The Company is engaged in the application of nanomedicine technologies to the... (more)
No analyst recommendations are available for .

Overall

Beta: 0.23
Market Cap(Mil.): $63.94
Shares Outstanding(Mil.): 63.31
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 89.38 16.52
EPS (TTM): -- -- --
ROI: -- 2.39 11.32
ROE: -- 3.35 15.18

BRIEF-NANOVIRICIDES SAYS HAS SUFFICIENT CASH TO ADVANCE INTO CLINICAL TRIALS

* NANOVIRICIDES HAS FILED ANNUAL REPORT, SAYS COMPANY HAS SUFFICIENT CASH TO ADVANCE INTO CLINICAL TRIALS

Sep 29 2017

Earnings vs. Estimates